Health & Life Sciences Advanced Discoveries
The health and life sciences industry has entered into an era of unprecedented innovation and technological change that require sophisticated legal counsel to navigate constantly-evolving political, economic, and regulatory landscapes and corresponding opportunities. Leveraging our integrated approach and years of unprecedented experience, Kilpatrick Townsend partners with clients in all sectors of health and life sciences to provide legal and business solutions involving transactional matters, regulatory compliance, and all aspects of dispute resolution worldwide. Our services cover the entire product lifecycle — from scientific discovery to product development and production to global marketing and distribution — so clients can more easily adapt to rapid changes in the marketplace and focus on long-term goals.
We work closely with U.S. and global entrepreneurs, startups, Fortune 100 companies, public and private research organizations, and academic institutions in all areas of health, chemistry, life sciences, biotech, pharmaceuticals, medical and surgical devices, and emerging technologies to help drive growth and bring innovations to life. Our attorneys advise on transactional, regulatory, and dispute matters involving Anti-Kickback, Stark, False Claims Act, HIPAA, and state privacy laws; Medicare and Medicaid reimbursement; option and contractual matters (clinical trial, supply, and distribution); licensing; research and development; acquisitions; integration; joint ventures; corporate structure; and compliance matters. We also handle other litigation and administrative matters that involve payor audits and appeals, health care fraud investigations and prosecutions, licensure issues, and disputes with and among insurance companies, physicians, and hospitals.
Our attorneys fully grasp the importance of grid, cloud, and other e-infrastructure integration within the health and life sciences industries, including its underlying technology components and associated emerging issues. With this insight, we routinely advise health and life science companies on raising capital, partnering, licensing, contracting, and general corporate matters, and we represent venture capital and private equity funds and other financing sources in their investment activities. Our attorneys also understand the increasing importance and value of this industry-generated data, including its role in reimbursement, related regulatory issues in data management, and the associated privacy, security, liability, and contractual concerns — giving us a distinct edge in advancing our clients’ success.
Matthew E. Hinsch
San Francisco, CA
Charles W. Calkins